Companies: 10,795·Total market cap: $144.5T
GlobeImmune, Inc.

GlobeImmune, Inc.

GBIMOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$575
P/E Ratio
52W High$0.0005
52W Low$0.000001
Overview

GlobeImmune, Inc.(GBIM)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · GBIM · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-0.36gbim eps ttm · gbim earnings per shareEarnings history
PE Ratio (TTM)gbim pe ratio ttm · gbim price to earningsPE Ratio deep dive
Revenue (TTM)$6.2Mgbim revenue ttm · gbim annual revenueFull revenue history
Dividend Yield不分红does gbim pay dividends · gbim dividend yieldDividend history
Shares Outstanding5.8Mgbim shares outstanding · gbim floatShares outstanding history
Next EarningsTBAgbim earnings date · gbim next earningsEarnings history

财务快照

完整财报
FY 2015Revenue$6.5M▲ +8.24% YoY
201320142015
globeimmune, inc. revenue · gbim revenue 2015
FY 2015Net Income-$2.8M▲ +86.27% YoY
201320142015
globeimmune, inc. net income · gbim profit 2015
FY 2015EPS$-0.48▲ +93.05% YoY
201320142015
gbim eps · globeimmune, inc. earnings per share 2015
TTM:Revenue: $6.2MNet Income: -$2.1MEPS: $-0.36View income statement →

股票表现

完整历史
1D+0.00%
1W+0.00%
1M+0.00%
3M+0.00%
YTD+0.00%
1Y-50.00%
5Y-99.99%

关于 GlobeImmune, Inc.

CEODonald Bellgrau
IPO DateJul 2, 2014
Employees2
CountryUS

GlobeImmune, Inc. a biopharmaceutical company, focuses on developing therapeutic products for cancer and infectious diseases based on proprietary Tarmogen platform. Its product candidate includes GS-…

what is globeimmune, inc. · gbim stock overview · globeimmune, inc. company profile · who is globeimmune, inc. ceo · gbim OTC · globeimmune, inc. headquarters · globeimmune, inc. business segments

关于股票概览与关键数据

GlobeImmune, Inc.(GBIM)是 Biotechnology 行业的 Healthcare 类公司,于 Jul 2, 2014 在 OTC 上市。截至最近交易日,GBIM 股价为 $0.00,市值约为 $575。过去12个月累计回报 -50.00%,年初至今回报 +0.00%。

2015 财年 GlobeImmune, Inc. 营收 $6.5M。完整财务数据(营收历史、盈利、资产负债表)请使用上方标签页。

常见问题

截至最近一个交易日,GlobeImmune, Inc.(GBIM)股价为 $0.00,在 OTC 上市,52周区间为 $0.00 – $0.00。

GBIM 最新股价GBIM quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 8, 2026本内容不构成投资建议